Shire plc Shire Plc : Director Declaration


Director Declaration

Dublin, Ireland - January 2, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG)

(the "Company") announces that Dominic Blakemore, Non-Executive Director

of the Company, was appointed Chief Executive of Compass Group PLC on

January 1, 2018.

For further information please contact:

Investor Relations

Christoph Brackmann +41 795 432 359

Robert Coates +44 203 549 0874

Sun Kim +1 617 588 8175


Lisa Adler +1 617 588 8607

Katie Joyce +1 781 482 2779


About Shire

Shire is the global leader in serving patients with rare diseases. We

strive to develop best-in-class therapies across a core of rare disease

areas including hematology, immunology, genetic diseases, neuroscience,

and internal medicine with growing therapeutic areas in ophthalmics and

oncology. Our diversified capabilities enable us to reach patients in

more than 100 countries who are struggling to live their lives to the


We feel a strong sense of urgency to address unmet medical needs and

work tirelessly to improve people's lives with medicines that have a

meaningful impact on patients and all who support them on their journey.

This announcement is distributed by Nasdaq Corporate Solutions on behalf

of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely

responsible for the content, accuracy and originality of the information

contained therein.

Source: Shire plc via Globenewswire

(END) Dow Jones Newswires

January 02, 2018 05:15 ET (10:15 GMT)